- Home
- RNXT vs ZCMD Comparison
RNXT vs ZCMD Comparison
Compare RNXT & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNXT | ZCMD |
|---|---|---|
| Founded | 2012 | 2012 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.4M | 16.8M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | RNXT | ZCMD |
|---|---|---|
| Price | $0.95 | $0.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.75 | N/A |
| AVG Volume (30 Days) | ★ 295.1K | 13.2K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $928,000.00 | ★ $13,117,523.00 |
| Revenue This Year | $2,795.35 | N/A |
| Revenue Next Year | $272.69 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.70 | $0.54 |
| 52 Week High | $1.69 | $2.36 |
Technical Indicators
Market Signals| Indicator | RNXT | ZCMD |
|---|---|---|
| Relative Strength Index (RSI) | 51.82 | 44.89 |
| Support Level | $0.92 | $0.58 |
| Resistance Level | $0.93 | $0.66 |
| Average True Range (ATR) | 0.05 | 0.05 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 81.94 | 59.63 |
Price Performance
Historical ComparisonAbout RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.